Clinical Trial Update: Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE) [Phase 1, Phase 2]

View source ↗

Summary

This update summarizes results from the ICICLE Phase 1/2 trial of CYT107 (interleukin-7) in idiopathic CD4+ T-lymphocytopenia. The study was terminated and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Cd4 T-lymphocytopenia

Drugs mentioned

• CYT107 (Interleukin-7) (interleukin-7)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Idiopathic CD4+ T-Lymphocytopenia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-10-15